logo
Hims & Hers Super Bowl controversy: What the ad left out about its 'alternative' weight-loss drugs

Hims & Hers Super Bowl controversy: What the ad left out about its 'alternative' weight-loss drugs

Yahoo11-02-2025

When you buy through links on our articles, Future and its syndication partners may earn a commission.
A Super Bowl commercial put out by the telehealth company Hims & Hers is drawing heat from critics who say the company's promotion of its weight-loss drugs misled consumers by leaving out key information.
At the center of the controversy are so-called compounded medications, which aren't regulated in the same way as brand-name or generic drugs are and aren't formally approved by the Food and Drug Administration (FDA).
In an ad spot that positioned Hims & Hers against "Big Pharma" and a system "leaving Americans sick and stuck," the company advertised itself as a service offering inexpensive GLP-1 agonists or semaglutides — the class of medications that includes Ozempic and Wegovy. The brand-name versions of these medications are FDA-approved to manage Type 2 diabetes and obesity, as well as related conditions like cardiovascular disease.
Hims & Hers offers compounded versions of these drugs, which are not FDA-approved.
Related: Ozempic-like meds linked to higher risk of pancreatitis, 'stomach paralysis' than other weight-loss drugs
It took an eagle eye to spot that disclaimer on the Hims & Hers ad, however, as it was printed in small white font on a gray background. The ad also did not follow a practice required for FDA-approved medications, which is listing possible side effects of the drugs and contraindications — meaning medical conditions or treatments that might prevent a person from using the drug safely.
That's a problem, according to critics.
"By mass marketing and mass producing compound medications, we are devolving the safety of our drug supply," said Shabbir Imber Safdar, the executive director of the Partnership for Safe Medicines, a nonprofit coalition of stakeholders in the drug supply chain, from manufacturers to wholesalers to patient advocates. "We're not having a debate about it, and we're not even educating Americans about it."
It's a common misconception that what clinics like Hims & Hers sell — at a fraction of the cost of branded pharmaceuticals — are generic versions of drugs. But compounded medications aren't generics, which must be manufactured with the same ingredients and by the same processes as brand-name pharmaceuticals.
Instead, compounded drugs are manufactured with the same active ingredients as generics and brand-names, but without the same regulations to control their production and labeling.
There are two places where compounded medications are made. The first is in small or neighborhood pharmacies, where pharmacists can customize small batches of drugs for patients with special needs. This is why compounded medications exist, Safdar told Live Science: A pharmacist may need to make a medication that is in shortage, or might need to somehow modify the "official" version of the drug. For example, they might make a liquid version of a drug only available in pill form for a patient who can't swallow pills, or they might replace a non-active ingredient for a patient with an allergy to it. These pharmacies are regulated under state pharmacy boards.
Compounded drugs can also be made in what are called bulk outsourcing facilities, some of which are very large. These facilities are inspected by the FDA for safety, and manufacturers must buy their ingredients from FDA-approved suppliers. But the resulting drugs and the process by which they are made aren't clinically tested, which is why the resulting drugs are not FDA-approved.
They are also not subject to the same supply-chain tracking as FDA-approved drugs are. Any FDA-approved medicine, whether generic or branded, has a unique serial number that links it back to its manufacturer. Compounded medicines don't fall under this requirement.
"A big problem, if a compounding facility makes you a drug that was prescribed by a doctor you've never met in person, is you're now holding a vial you're expected to inject into yourself and there's actually no way to know where it came from," Safdar said.
If there's a problem, it's more difficult to pinpoint who's liable, and more challenging to investigate if more users of the drug might be impacted. Track-and-trace also prevents counterfeit drugs from entering the system.
Looser labeling requirements for compounded versions of GLP-1s can also lead to confusion about dosage, according to an FDA alert issued in July 2024. The agency had received reports of patients being hospitalized after accidental dosing errors with compounded weight-loss drugs. There have also been alarms about compounding pharmacies using different versions of the active ingredients in these medications, leading to adverse events.
Compounded medications have led to tragedy before. In 2012, unsanitary conditions at a compounding pharmacy caused a 20-state outbreak of fungal meningitis that killed 64 people and infected nearly 800 others.
Related: Childhood obesity should be treated early and aggressively, new guidelines say. Is that safe?
Hims & Hers uses compounded semaglutide only from FDA-regulated bulk outsourcing facilities, said Dr. Craig Primack, the company's senior vice president of weight loss. Patients can check the testing related to their batch of medication on the company's app, Primack told Live Science.
This testing covers bacterial and viral contamination, impurities, and whether the concentration of the drug is correct. Primack said that because Hims & Hers is not a drug manufacturer, the company is not subject to the FDA's doctrine of fair balance, which requires that product advertisements include information about risks and side effects alongside benefits. Patients get that information during the consultation and prescription process, he said.
However, the idea that providers of compounded medications don't have to list side effects or risks has gotten pushback from Senators Riachard Durbin (D-IL) and Roger Marshall (R-KS). They wrote a letter to the FDA Friday (Feb. 7) expressing concern that the lack of fair balance is a loophole for those selling compounded medications.
RELATED STORIES
–Ozempic-style drugs tied to more than 60 health benefits and risks in biggest study-of-its-kind
–Ozempic-like drugs may treat alcohol addiction
–Fat cells have a 'memory' of obesity
"To the extent this falls within a regulatory loophole for the FDA's authorities, we plan to soon introduce bipartisan legislation to close this gap," Durbin and Marshall wrote.
Companies like Hims & Hers are allowed to offer compounded versions of Ozempic and Wegovy because the brand-name drugs are in shortage and have been for years. For consumers, it's an appealing option: The company offers brand-name Ozempic for $1,799 a month, out of pocket, while their compounded semaglutide starts at just $165 a month.
But compounding was never meant to provide a cheaper, mass-market version of FDA-approved medications, Safdar said. Nor were patients ever meant to have to navigate the difference, he emphasized.
"We need compounding," Safdar said. "But the rules were designed [the way they were] because no one ever thought we would have wide-scale usage of these medications."
The Hims & Hers Super Bowl commercial signals a potential shift in this status quo — one that may soon get its moment for debate if Durbin and Marshall's bill moves forward.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Is There an Azstarys Shortage?
Is There an Azstarys Shortage?

Health Line

time37 minutes ago

  • Health Line

Is There an Azstarys Shortage?

Azstarys is a prescription drug used to treat ADHD. Some ADHD medications have recently been in short supply. Learn whether Azstarys is affected and how to check its availability. Azstarys is not currently listed in the Food and Drug Administration (FDA) drug shortages database. Here's what to know about why some ADHD medications may be hard to find and how to check for drug shortages. Is there a shortage of other ADHD drugs? In recent years, several ADHD medications have been in short supply. A few examples include Adderall, Concerta, Ritalin, and Vyvanse. It's not yet clear when these shortages will fully resolve. These shortages have affected both brand-name and generic versions of the drugs. As a result, some people have worked with their doctor to switch to a different medication or adjust their ADHD treatment plan. To check the current status of Aztarys and other ADHD medications, visit the FDA drug shortages website. How do ADHD drug shortages affect people? Shortages of ADHD medications can make it harder for people to stick with their treatment plan. This can cause ADHD symptoms to return or become more difficult to manage. A lack of consistent access to ADHD medication may also increase stress and affect mental health. Other possible effects of disrupted access to ADHD medication include: difficulty focusing or completing daily tasks increased impulsivity or emotional outbursts difficulty falling or staying asleep withdrawing from social, family, or work activities If you're having trouble filling a prescription for an ADHD medication, talk with your doctor or pharmacist. They may recommend alternatives or adjust your treatment plan based on what's available. What causes a drug shortage? Several factors can lead to a medication being in short supply. Common causes of ADHD drug shortages include: Increased demand: More people receiving diagnoses of ADHD have led to greater demand for medications. This can strain manufacturers and reduce availability at pharmacies. Regulatory limits: Stimulant medications used to treat ADHD, including Azstarys, are controlled substances. The Drug Enforcement Administration (DEA) sets yearly production limits for these medications. If demand rises suddenly, these limits may contribute to shortages. Supply chain issues: Shortages of raw materials, packaging supplies, or labor can delay the manufacturing and availability of ADHD drugs. When multiple ADHD medications are in short supply at the same time, it can be especially hard for pharmacies to keep any option in stock. Even when generic forms are available, they may be affected by the same issues as brand-name drugs. As a result, generics may be just as difficult to find during a shortage. How can I check whether Azstarys is available near me? Azstarys is not currently listed by the FDA as being in shortage. However, some people may still experience delays when trying to fill their prescription. Availability can vary depending on your pharmacy, location, and insurance plan. If you're having trouble finding Azstarys, start by talking with a pharmacist. If possible, visit the pharmacy in person. Some pharmacies may not share inventory details for ADHD medications over the phone. You can also check pharmacy websites or apps, which sometimes offer tools to look up availability online. Keep in mind that availability may change as new shipments arrive. You can also check with your insurance provider. If Azstarys isn't available through your plan's preferred pharmacy, your insurer may be able to help you locate another pharmacy. In some cases, you may want to reach out to the drug manufacturer for information about availability in your area. To learn more about contacting the manufacturer, visit the Azstarys website.

MemoDefend Announces Official Website Update Featuring Natural Daily Supplement for Cognitive Support
MemoDefend Announces Official Website Update Featuring Natural Daily Supplement for Cognitive Support

Yahoo

timean hour ago

  • Yahoo

MemoDefend Announces Official Website Update Featuring Natural Daily Supplement for Cognitive Support

Natural Brain Health Formula Now Available Online to Support Memory, Focus, and Cognitive Function in Adults Lakeland, June 09, 2025 (GLOBE NEWSWIRE) -- MemoDefend, a Florida-based wellness brand, has updated its official website to provide consumers with new information about its daily supplement formulated to support cognitive clarity and brain function in adults. Now available nationwide, the natural memory support formula is designed for individuals seeking a consistent, easy-to-integrate wellness solution. According to the official product website ( MemoDefend is intended to work in harmony with the body's internal processes to support healthy memory retention, mental sharpness, and overall cognitive performance. The brand highlights its approach as one that simplifies brain wellness without requiring restrictive regimens or complicated routines. 'We developed MemoDefend to help adults support brain health naturally—without disrupting their lifestyle,' said a company spokesperson. 'This product reflects our focus on purity, simplicity, and long-term wellness.' The company states that MemoDefend is produced in facilities that follow strict quality control practices. Its formulation features a selection of ingredients that align with adult wellness priorities such as cognitive support, mental clarity, and healthy aging. As noted on the website, MemoDefend includes a satisfaction guarantee for new customers. Those interested in learning more about its intended use or placing an order can find full details, customer support access, and purchasing options directly at the official website. About MemoDefend MemoDefend is a Lakeland, Florida-based wellness brand committed to delivering natural, easy-to-use supplements that support everyday health routines. Focused on transparency and simplicity, the company develops formulas to help adults feel more confident in their wellness journey—one daily step at a time. Product and Contact Information Brand: MemoDefendWebsite: support@ +1 (888) 535-1590Mailing Address: P.O. Box 90129, Lakeland, FL 33804, United States Disclaimer This release is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. The statements made about this product have not been evaluated by the Food and Drug Administration. Individual results may vary. Consumers should consult a qualified healthcare provider before beginning any new dietary supplement. CONTACT: Email: support@ Phone: +1 (888) 535-1590Sign in to access your portfolio

Appendix cancer has quadrupled in older millennials in the US
Appendix cancer has quadrupled in older millennials in the US

New York Post

timean hour ago

  • New York Post

Appendix cancer has quadrupled in older millennials in the US

Researchers are reporting a startling spike in appendiceal adenocarcinoma (AA) — otherwise known as appendix cancer — in people born after 1945. Cases have more than tripled in Americans born between 1980 and 1985 and quadrupled in those born between 1985 and 1990, according to a new study out of Vanderbilt University Medical Center. 'I think it's alarming,' study author Andreana N. Holowatyj, an assistant professor of hematology and oncology, told The Post. Advertisement 3 A new study has identified an alarming spike in appendiceal adenocarcinoma (AA) — otherwise known as appendix cancer — in people born after 1945. top images – Appendix cancer is very rare, estimated to affect only about one or two people per 1 million per year, according to the National Cancer Institute. Indeed, Holowatyj's team identified only 4,858 people aged 20 and over who were diagnosed with AA between 1975 and 2019. Advertisement The findings, published Monday in the Annals of Internal Medicine, are nonetheless part of a troublesome trend. AA is yet another type of cancer that seems to be on the rise in younger adults — joining the ranks of colorectal, breast, uterine, kidney and pancreatic cancers. 'I think the fact that we're seeing birth cohort or generational effects across a plethora of cancer types is indeed alarming because it really stresses the need to understand what is underpinning this pattern in order for us to be able to actively reverse it,' Holowatyj said. 3 Experts point to lifestyle changes, such as more sedentary behavior, as a possible cause of the rise in cancer cases in younger people. StockPhotoPro – Advertisement As with other cancers, health experts aren't exactly sure what could be causing the jump in AA cases. 'I think it's going to be a constellation of factors that may be driving appendiceal cancer development,' Holowatyj said. 'One of the things we often think about is, what has changed across birth cohorts over time?' she said. Advertisement Holowatyj pointed to 'possibly the use of antibiotics, both in childhood and in the food chain, the industrialization of the food industry over time, the lifestyle patterns and the tripling of obesity since the 1970s, increasingly sedentary behavior, possibly environmental exposures that have changed across different parts of the country and over time.' Whatever the cause, she hopes this study encourages the public to be 'aware of this cancer, to know about the signs and symptoms of appendix cancers and know that we're seeing more cases diagnosed across generations.' 3 Most AA cases are diagnosed incidentally after someone has their appendix removed. Avocado_studio – Many of these symptoms can mimic appendicitis: Abdominal pain, often on the lower right side Bloating, diarrhea or constipation Feeling full after small meals Unexplained weight loss Nausea and vomiting Abdominal mass or swelling Holowatyj hopes that people with symptoms 'see a healthcare professional in a timely manner because it's truly critical to detect appendix cancer early.' There are no standardized screening tests for appendix cancers — most cases are diagnosed incidentally after someone has their appendix removed. 'I think it's important to understand that appendix cancer is actually diagnosed in younger ages more commonly than we see in other cancers,' she said, noting that one in three patients diagnosed with appendix cancer is under the age of 50, compared to one in eight for colon cancer.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store